Your trusted destination for CME, CPD & Medical Education across the Middle East.
The 4th GCC Hematology Hub 2026 is a regional hematology conference taking place on 28–29 November 2026 at Sofitel Abu Dhabi Corniche, Abu Dhabi, UAE. The event will bring together hematology and oncology professionals to discuss advances in diagnosis, treatment, and patient care. It will provide opportunities for scientific exchange, interactive learning, networking, and collaboration with regional and international experts
The 4th GCC Hematology Hub 2026 is a leading regional platform dedicated to advancing hematology education, professional development, and collaboration. The conference will feature keynote lectures, scientific sessions, symposia, and case-based panel discussions addressing rapidly evolving developments in hematology. More than 30 expert faculty and key opinion leaders are expected to contribute to the scientific program, which includes 45+ interactive talks and 8+ sessions. The event will explore emerging evidence, innovative treatment approaches, and practical strategies for improving patient outcomes. It will also provide healthcare professionals with opportunities to exchange knowledge, build professional networks, and establish collaborations across the GCC and beyond. The conference is scheduled as a hybrid event, combining in-person participation in Abu Dhabi with digital access. The full scientific program and faculty list are still being announced by the organizers.
Exploring the latest innovative treatments and pharmacological advances for hematological disorders.
Advancements in precision medicine and targeted therapies for blood cancers.
The evolving role of immune-based treatments in managing complex hematological malignancies.
Implementing current best practices and clinical guidelines in daily hematology practice.
Strategies to restore function and enhance the overall well-being of patients.
Comprehensive, multidisciplinary approaches to managing chronic hematological conditions.
Highlighting GCC-specific research, epidemiological data, and publication support.
Updates on ongoing and upcoming clinical trials within the region and globally.
Reviewing new literature, breakthrough studies, and their clinical implications.
Latest updates in the management of hemophilia and other coagulation abnormalities.
Advances in the diagnosis and treatment of leukemias, lymphomas, and myelomas.
Addressing non-malignant blood disorders such as anemias and hemoglobinopathies.
This conference features CME-accredited activities. Specific credit hours and accrediting bodies will be officially announced on November 1, 2026.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
